The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of proton pump inhibitors on the pathological complete response rate in luminal breast cancer during neoadjuvant therapy.
 
Eduardo Richardet
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb
Research Funding - Amgen; Astellas Pharma; Bristol-Myers Squibb; Janssen; Merck Sharp & Dohme; Novartis/Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer
 
Santos Depetris
No Relationships to Disclose
 
Nicolas Higa Tamashiro
No Relationships to Disclose
 
Marcos Ledesma
No Relationships to Disclose
 
Pablo Perea
No Relationships to Disclose
 
Martin Richardet
Research Funding - Amgen; Astellas Pharma; Boehringer Ingelheim; Merck Sharp & Dohme; Novartis/Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Roche; Merck
 
Matias Molina
No Relationships to Disclose